Recruiting Huntingtons Disease Studies in Dothan
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid anxiety...
Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
This study will evaluate the efficacy, safety and pharmacokinetics of HLD200 (20 mg and 40 mg) in children aged 4 to 5 years with ADHD....
About Huntingtons Disease Clinical Trials in Dothan
Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.
There are currently 2 huntingtons disease clinical trials recruiting participants in Dothan, ALABAMA. These studies are seeking a combined 476 participants. Research is being sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., Ironshore Pharmaceuticals and Development, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Huntingtons Disease Clinical Trials in Dothan — FAQ
Are there huntingtons disease clinical trials in Dothan?
Yes, there are 2 huntingtons disease clinical trials currently recruiting in Dothan, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dothan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dothan research site will contact you about next steps.
Are clinical trials in Dothan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dothan studies also compensate for your time and travel.
What huntingtons disease treatments are being tested?
The 2 active trials in Dothan are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.
Data updated March 2, 2026 from ClinicalTrials.gov